Selected issues in antibiotic resistance

Infections in Medicine

Volumn 21, Issue 3, 2004, Pages 114-122

  Gleckman, Richard A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellulitis; Drus resistance; Infection; Pneumonia; Urinary tract

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFIXIME; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; IMIPENEM; INFLUENZA VACCINE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; OSELTAMIVIR; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL STRAIN; BRONCHITIS; CELLULITIS; CYSTITIS; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG SAFETY; GONOCOCCAL URETHRITIS; HEALTH CARE COST; HUMAN; INFECTION CONTROL; MAXILLA SINUSITIS; MORBIDITY; MORTALITY; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIA; TREATMENT FAILURE;

EID: 16544379888     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol. 2003;24:251-256.
2. Smith DW. Decreased antimicrobial resistance following changes in antibiotic use. Surg Infect. 2000;1:73-78
3. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347.
4. Joshi SG, Litake GM, Niphadkar KB, Ghole VS. Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother. 2003;9:187-190.
5. Karlowsky JA, Kelly LJ, Thornsberry C, et al. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002;46:2540-2545.
6. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis. 2003;36:183-187.
7. Nicolle LE. Asymptomatic bacteriuria: when to screen and when to treat. Infect Dis Clin North Am. 2003;17:367-394.
8. Jepson RG, Mihaljevic, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2001;3:CD001321.
9. Chowdhry S, Pandhi D, Vidhani S, et al. High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gono coccal urethritis in Delhi. Int J STD AIDS. 2002; 13:564-567.
10. Increases in fluoroquinolone-resistant Neisseria gonorrrhoeae - Hawaii and California, 2001. MMWR. 2002;51:1041-1044.
11. Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Micrbiol. 1999;26:267-276.
12. Hirschmann JV. Antibiotics for common respiratory tract infections in adults. Arch Intern Med. 2002;162:256-264.
13. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003;138:525-533.
14. Bucher HC, Tschudi P, Young J, et al. Effect of amoxicillin-clavulanate in chrucally diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Arch Intern Med. 2003;163:1793-1798.
15. Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2000;30:520-528.
16. Luh JY, Karnath BM. Nonspecific guidelines lead to inappropriate fluoroquinolone use. Arch Intern Med. 2003;163:1617-1618.
17. Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667-1672.
18. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348:1747-1755.
19. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
20. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-1377.
21. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
22. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
23. Tunkel AR, Scheld WM. Corticosteroids for everyone with meningitis? N Engl J Med. 2002; 347:1613-1615.